EUVIMEDEUVIMED entdecken
Systematische ÜbersichtStudienprotokollOpen Access · CC BY 4.0

Treating rosacea with botulism toxin: Protocol for a systematic review and meta‐analysis

Guanjin He, Qifeng Yang, Jin Wu, Yuanen Huang, Huilan Zheng, Hongbin Cheng

Journal of Cosmetic Dermatology · 2024

DOI: 10.1111/jocd.15962 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Guanjin He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Botulism, Rosacea. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rosacea is a chronic inflammatory disease usually associated with persistent erythema and periodic flushing. This disease is difficult to treat, and the outcomes are often unsatisfactory and prone to recurrence. In recent years, botulinum toxin has been used as a new treatment for rosacea; however, its efficacy and safety remain under discussion. Although a systematic review of the effectiveness and safety of botulinum toxin has been previously conducted by other researchers, our systematic review and meta‐analysis evaluate the efficacy of botulinum toxin from a more comprehensive and detailed perspective to provide evidence for clinicians.

Methods

Any study using botulinum toxin for the treatment of rosacea was considered for the analysis.

Results

A total of 22 studies were included, 9 of which were randomized controlled trials involving 720 subjects. After treatment, all studies showed varying degrees of improvement in patient signs and symptoms along with reduced Clinician's Erythema Assessment (CEA) scores. The improvement was maintained for several months, and the adverse effects were mild and self‐limiting.

Conclusion

Botulinum toxin may be an effective treatment for patients with rosacea; however, further clinical evidence is needed to confirm its long‐term efficacy and side effects. The study was preregistered with Prospero (CRD42022358911).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type ABotulismRosaceaHumansErythemaMeta-Analysis as TopicRandomized Controlled Trials as TopicSystematic Reviews as TopicTreatment Outcome

Stichwörter der Autor:innen

botulinum toxin type Aexternal applicationintradermal injectionmeta-analysisrosacea

Substanzen

Botulinum Toxins, Type A

Autor:innen und Institutionen

  • Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Zitieren

APA

He, G., Yang, Q., Wu, J., Huang, Y., Zheng, H., & Cheng, H. (2024). Treating rosacea with botulism toxin: Protocol for a systematic review and meta‐analysis. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.15962

Vancouver

He G, Yang Q, Wu J, Huang Y, Zheng H, Cheng H. Treating rosacea with botulism toxin: Protocol for a systematic review and meta‐analysis. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.15962

BibTeX
@article{He2024,
  author = {He, Guanjin and Yang, Qifeng and Wu, Jin and Huang, Yuanen and Zheng, Huilan and Cheng, Hongbin},
  title = {Treating rosacea with botulism toxin: Protocol for a systematic review and meta‐analysis},
  journal = {Journal of Cosmetic Dermatology},
  year = {2024},
  doi = {10.1111/jocd.15962}
}
Kostenlos starten →